EPISODE · Dec 22, 2022 · 29 MIN
239: 2022 in review, CEO indictments, & the year ahead
from The Readout Loud · host STAT
We look back on the biggest biotech stories of 2022 and how, despite some meaningful advances in Alzheimer's disease and gene therapy, the industry seems stuck in a sentiment rut. We also discuss the latest news in the life sciences, including a pair of indicted CEOs and the debate over how much an oft-debated new medicine should cost.
Embed this episode
NOW PLAYING
239: 2022 in review, CEO indictments, & the year ahead
0:00
29:27
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Readout Loud?
This episode is 29 minutes long.
When was this The Readout Loud episode published?
This episode was published on December 22, 2022.
Can I download this The Readout Loud episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!